BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20084709)

  • 1. Anemia in patients with advanced or metastatic non-small cell lung cancer.
    Abuzallouf S; Wright J; El Hattab O
    Gulf J Oncolog; 2007 Jan; 1(1):17-21. PubMed ID: 20084709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.
    Wright JR; Ung YC; Julian JA; Pritchard KI; Whelan TJ; Smith C; Szechtman B; Roa W; Mulroy L; Rudinskas L; Gagnon B; Okawara GS; Levine MN
    J Clin Oncol; 2007 Mar; 25(9):1027-32. PubMed ID: 17312332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
    Ariganello O; Mancuso A; Di Molfetta M; Diana F; Beccaglia P; Cortesi E; De Marinis F
    Lung Cancer; 2004 Oct; 46(1):119-24. PubMed ID: 15364140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?
    Chamogeorgakis T; Anagnostopoulos C; Kostopanagiotou G; Bhora F; Toumpoulis I; Georgiannakis E; Nabong A; Dosios T; Harrison L; Connery C
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):148-53. PubMed ID: 18365973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer.
    Panagopoulos ND; Karakantza M; Koletsis E; Apostolakis E; Sakellaropoulos GC; Filos KS; Eleni T; Dougenis D
    Lung Cancer; 2008 Nov; 62(2):273-80. PubMed ID: 18430486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B; van de Werf PR; Melissant CF; Brok RG
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?
    Kosmidis P; Krzakowski M;
    Lung Cancer; 2005 Dec; 50(3):401-12. PubMed ID: 16191450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study.
    de Castro J; Belda-Iniesta C; Isla D; Dómine M; Sánchez A; Batiste E; Barón MG
    Lung Cancer; 2008 Feb; 59(2):211-8. PubMed ID: 17875340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diabetes mellitus on the outcome of patients with resected non-small cell lung carcinoma.
    Bartling B; Simm A; Sohst A; Silber RE; Hofmann HS
    Gerontology; 2011; 57(6):497-501. PubMed ID: 21411967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experience.
    Gauthier I; Ding K; Winton T; Shepherd FA; Livingston R; Johnson DH; Rigas JR; Whitehead M; Graham B; Seymour L
    Lung Cancer; 2007 Mar; 55(3):357-63. PubMed ID: 17141357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestation and survival of patients with non-small cell lung cancer.
    Thammakumpee K
    J Med Assoc Thai; 2004 May; 87(5):503-7. PubMed ID: 15222519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
    Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
    Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers.
    Berardi R; Brunelli A; Tamburrano T; Verdecchia L; Onofri A; Zuccatosta L; Gasparini S; Santinelli A; Scartozzi M; Valeri G; Giovagnoni A; Giuseppetti GM; Fabris G; Marmorale C; Fianchini A; Cascinu S
    Lung Cancer; 2005 Sep; 49(3):371-6. PubMed ID: 15951051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of anemia and chronic kidney disease in cancer patients: clinical significance for 1-year mortality].
    Nakamura Y; Tsuchiya K; Nitta K; Ando M
    Nihon Jinzo Gakkai Shi; 2011; 53(1):38-45. PubMed ID: 21370576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insertion of self expanding metal stents with flexible bronchoscopy under sedation for malignant tracheobronchial stenosis: a single-center retrospective analysis.
    McGrath EE; Warriner D; Anderson P
    Arch Bronconeumol; 2012 Feb; 48(2):43-8. PubMed ID: 22137422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-weekly epoetin beta (30,000 IU) in anemic patients with lung cancer receiving chemotherapy.
    Pirker R; Lehnert M; Minar W
    Lung Cancer; 2007 Jan; 55(1):89-94. PubMed ID: 17084484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer.
    Lara PN; Douillard JY; Nakagawa K; von Pawel J; McKeage MJ; Albert I; Losonczy G; Reck M; Heo DS; Fan X; Fandi A; Scagliotti G
    J Clin Oncol; 2011 Aug; 29(22):2965-71. PubMed ID: 21709202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.